Table 1

Characteristics of the 696 patients included in the final study analysis

AlgorithmCOPD Code+spirometry+COPD medicationCOPD Code+spirometryCOPD Code+COPD medicationCOPD Code onlyBronchitis+COPD medicationBronchitis onlySymptoms+spirometrySymptoms only
Number of individuals (%)85 (100)79 (100)88 (100)89 (100)98 (100)84 (100)83 (100)90 (100)
Number (%) with supporting info46 (54.1)44 (55.7)48 (54.5)40 (44.9)32 (32.7)18 (21.4)30 (36.1)14 (15.6)
Mean age (SD)68.7 (11.3)68.3 (11.7)71.8 (10.5)71.1 (10.4)68.5 (13.1)67.8 (13.4)65.9 (11.9)63.4 (14.1)
Male (%)45 (52.9)41 (51.9)40 (45.5)44 (49.4)31 (31.6)29 (34.5)43 (51.8)47 (52.2)
Current smoker (%)49 (57.7)50 (63.3)55 (62.5)47 (52.8)66 (67.4)61 (72.6)48 (57.8)58 (64.4)
GOLD stage (n=465)*
 113 (16.3)14 (18.0)13 (15.9)16 (20.5)17 (28.8)13 (35.1)8 (20.0)4 (36.4)
 243 (53.8)48 (61.5)41 (50.0)46 (59.0)31(52.5)13 (35.1)22 (55.0)5 (45.5)
 318 (22.5)13 (16.7)22 (26.8)12 (15.4)9 (15.3)8 (21.6)8 (20.0)2 (18.2)
 46 (7.5)3 (3.9)6 (7.3)4 (5.1)2 (3.4)3 (8.1)2 (5.0)0 (0.0)
History of cardiovascular disease20 (23.5)22 (27.8)17 (19.3)18 (20.2)20 (20.4)17 (20.2)14 (16.9)9 (10.0)
History of asthma18 (21.2)20 (25.3)16 (18.2)15 (16.9)27 (27.6)23 (27.4)19 (22.9)23 (25.6)
Mean BMI (SD) (n=575)N=83
27.5 (5.4)
N=78
26.7 (5.8)
N=86
26.4 (4.7)
N=87
27.8 (5.4)
N=98
27.4 (5.1)
N=85
28.1 (5.0)
N=41
27.1 (4.5)
N=17
27.6 (4.7)
  • *GOLD staging was ascertained from CPRD records or from supplementary information provided by GPs.

  • BMI, body mass index; COPD, chronic obstructive pulmonary disease; CPRD, Clinical Practice Research Datalink; GOLD, Global initiative for Chronic Obstructive Lung Disease; GP, general practitioner.